Literature DB >> 15197720

Deep brain stimulation in myoclonus-dystonia syndrome.

Laura Cif1, Enza Maria Valente, Simone Hemm, Christine Coubes, Nathalie Vayssiere, Stéphanie Serrat, Annalisa Di Giorgio, Philippe Coubes.   

Abstract

Myoclonus-dystonia syndrome (MDS) is an autosomal dominant disorder characterized by bilateral myoclonic jerks. An 8-year-old boy presenting with early onset, medically intractable, MDS due to a mutation in the epsilon-sarcoglycan gene (SGCE) underwent chronic bilateral stimulation of the globus pallidus internus, which eliminates both myoclonus and dystonia. We conclude that deep brain stimulation can be an effective and safe treatment for MDS. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197720     DOI: 10.1002/mds.20030

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Bilateral Deep Brain Stimulation of the Globus Pallidus Pars Interna in a Patient with Variant Ataxia-Telangiectasia.

Authors:  Dejan Georgiev; Dwij Mehta; André Zacharia; Ruben Saman Vinke; Catherine Milabo; Joseph Candelario; Elina Tripoliti; Jonathan A Hyam; Ludvic Zrinzo; Marwan Hariz; Seán O'Riordan; Thomas Foltynie; Patricia Limousin
Journal:  Mov Disord Clin Pract       Date:  2016-01-21

Review 2.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

3.  Childhood dystonias.

Authors:  Samer D Tabbal
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

4.  Myoclonic disorders: a practical approach for diagnosis and treatment.

Authors:  Maja Kojovic; Carla Cordivari; Kailash Bhatia
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

5.  Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation.

Authors:  Kristoffer Haugarvoll; Charalampos Tzoulis; Gia T Tran; Bjørn Karlsen; Bernt A Engelsen; Per M Knappskog; Laurence A Bindoff
Journal:  J Neurol       Date:  2013-12-03       Impact factor: 4.849

6.  Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen.

Authors:  Napala R Pratini; Nancy Sweeters; Elliott Vichinsky; Jacob A Neufeld
Journal:  Am J Phys Med Rehabil       Date:  2013-08       Impact factor: 2.159

7.  Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome.

Authors:  Alexis M Kuncel; Dennis A Turner; Laurie J Ozelius; Paul E Greene; Warren M Grill; Mark A Stacy
Journal:  Clin Neurol Neurosurg       Date:  2008-12-10       Impact factor: 1.876

8.  Myoclonus.

Authors:  Victoria C Chang; Steven J Frucht
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

9.  An evaluation of rating scales utilized for deep brain stimulation for dystonia.

Authors:  Frandy Susatia; Irene A Malaty; Kelly D Foote; Samuel S Wu; Pamela R Zeilman; Mitushi Mishra; Ramon L Rodriguez; Ihtsham ul Haq; Charles E Jacobson; Anqi Sun; Michael S Okun
Journal:  J Neurol       Date:  2009-07-29       Impact factor: 4.849

10.  Clinical and neurophysiological improvement of SGCE myoclonus-dystonia with GPi deep brain stimulation.

Authors:  Monica M Kurtis; Marta San Luciano; Qiping Yu; Robert R Goodman; Blair Ford; Deborah Raymond; Seth L Pullman; Rachel Saunders-Pullman
Journal:  Clin Neurol Neurosurg       Date:  2009-11-05       Impact factor: 1.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.